The US agency has given the go-ahead to Cour Pharmaceuticals to evaluate the safety and efficacy of CNP-201, a drug intended to treat peanut allergies.
An Oxford University trial, a world first, is looking at whether inoculating volunteers with doses of different combinations of two currently approved COVID-19 vaccines is effective.
Sanofi Pasteur has entered into a license and supply agreement with
Eisai for the use of their novel adjuvant designed to boost the
immune response to a broad range of vaccines.
US company Sontra Medical has successfully completed the first
tests of a novel technology that allows vaccines to be applied
topically to the skin, rather than delivered through a needle.
Preliminary data suggest the method is as...
Researchers in the US have taken an important step toward creating
a vaccine against Alzheimer's disease, overcoming the side effects
that held back a prior vaccine for the disease.